Shares of Fortis Healthcare were trading higher at Rs 951.65, a 2.03% increase from the previous close, in Monday's session. The stock is a constituent of the Nifty Midcap 150 index.
Financial Overview
The following tables provide a detailed look into the financial performance of Fortis Healthcare.
Consolidated Quarterly Results
Key figures from the consolidated quarterly income statement:
| Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | |
|---|---|---|---|---|---|
| Sales | Rs 2,166 Crore | Rs 2,007 Crore | Rs 1,928 Crore | Rs 1,988 Crore | Rs 1,858 Crore |
| Other Income | Rs 15 Crore | Rs 19 Crore | Rs 20 Crore | Rs 13 Crore | Rs 13 Crore |
| Total Income | Rs 2,182 Crore | Rs 2,027 Crore | Rs 1,949 Crore | Rs 2,001 Crore | Rs 1,871 Crore |
| Total Expenditure | Rs 1,764 Crore | Rs 1,727 Crore | Rs 1,626 Crore | Rs 1,708 Crore | Rs 1,607 Crore |
| EBIT | Rs 417 Crore | Rs 299 Crore | Rs 322 Crore | Rs 293 Crore | Rs 264 Crore |
| Interest | Rs 69 Crore | Rs 67 Crore | Rs 45 Crore | Rs 36 Crore | Rs 35 Crore |
| Tax | Rs 83 Crore | Rs 48 Crore | Rs 25 Crore | Rs 67 Crore | Rs 56 Crore |
| Net Profit | Rs 263 Crore | Rs 183 Crore | Rs 252 Crore | Rs 188 Crore | Rs 173 Crore |
The revenue for the quarter ending June 2025 was Rs 2,166.72 Crore, an increase compared to Rs 2,007.20 Crore for the quarter ending March 2025. Net profit for the same period was Rs 263.86 Crore, up from Rs 183.38 Crore in the previous quarter.
Consolidated Yearly Results
Key figures from the consolidated yearly income statement:
| Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | |
|---|---|---|---|---|---|
| Sales | Rs 7,782 Crore | Rs 6,892 Crore | Rs 6,297 Crore | Rs 5,717 Crore | Rs 4,030 Crore |
| Other Income | Rs 66 Crore | Rs 38 Crore | Rs 61 Crore | Rs 27 Crore | Rs 46 Crore |
| Total Income | Rs 7,849 Crore | Rs 6,931 Crore | Rs 6,359 Crore | Rs 5,744 Crore | Rs 4,076 Crore |
| Total Expenditure | Rs 6,669 Crore | Rs 5,951 Crore | Rs 5,438 Crore | Rs 4,634 Crore | Rs 3,915 Crore |
| EBIT | Rs 1,179 Crore | Rs 979 Crore | Rs 920 Crore | Rs 1,110 Crore | Rs 161 Crore |
| Interest | Rs 184 Crore | Rs 130 Crore | Rs 129 Crore | Rs 146 Crore | Rs 165 Crore |
| Tax | Rs 197 Crore | Rs 212 Crore | Rs 180 Crore | Rs 197 Crore | Rs 99 Crore |
| Net Profit | Rs 797 Crore | Rs 635 Crore | Rs 611 Crore | Rs 765 Crore | Rs -103 Crore |
The annual sales for the year ending March 2025 stood at Rs 7,782 Crore compared to Rs 6,892 Crore in March 2024. The net profit for the same period was Rs 797.86 Crore, up from Rs 635.71 Crore.
Cash Flow
The cash flow statement provides an overview of the company's cash inflows and outflows:
| Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | |
|---|---|---|---|---|---|
| Operating Activities | Rs 1,423 Crore | Rs 1,100 Crore | Rs 822 Crore | Rs 865 Crore | Rs 485 Crore |
| Investing Activities | Rs -779 Crore | Rs -886 Crore | Rs -373 Crore | Rs -514 Crore | Rs -135 Crore |
| Financing Activities | Rs -713 Crore | Rs -86 Crore | Rs -471 Crore | Rs -517 Crore | Rs -142 Crore |
| Others | Rs 0 Crore | Rs -2 Crore | Rs 1 Crore | Rs 13 Crore | Rs 4 Crore |
| Net Cash Flow | Rs -69 Crore | Rs 124 Crore | Rs -21 Crore | Rs -152 Crore | Rs 212 Crore |
The balance sheet provides a snapshot of the company's assets, liabilities, and equity:
| Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | |
|---|---|---|---|---|---|
| Share Capital | Rs 754 Crore | Rs 754 Crore | Rs 754 Crore | Rs 754 Crore | Rs 754 Crore |
| Reserves & Surplus | Rs 8,161 Crore | Rs 6,906 Crore | Rs 6,485 Crore | Rs 5,423 Crore | Rs 5,362 Crore |
| Current Liabilities | Rs 1,607 Crore | Rs 3,170 Crore | Rs 1,425 Crore | Rs 1,269 Crore | Rs 1,233 Crore |
| Other Liabilities | Rs 3,167 Crore | Rs 2,457 Crore | Rs 3,767 Crore | Rs 4,437 Crore | Rs 3,803 Crore |
| Total Liabilities | Rs 13,691 Crore | Rs 13,288 Crore | Rs 12,433 Crore | Rs 11,884 Crore | Rs 11,154 Crore |
| Fixed Assets | Rs 6,636 Crore | Rs 6,221 Crore | Rs 5,513 Crore | Rs 5,485 Crore | Rs 5,242 Crore |
| Current Assets | Rs 1,471 Crore | Rs 1,420 Crore | Rs 1,406 Crore | Rs 1,133 Crore | Rs 1,036 Crore |
| Other Assets | Rs 5,584 Crore | Rs 5,646 Crore | Rs 5,514 Crore | Rs 5,265 Crore | Rs 4,875 Crore |
| Total Assets | Rs 13,691 Crore | Rs 13,288 Crore | Rs 12,433 Crore | Rs 11,884 Crore | Rs 11,154 Crore |
| Contingent Liabilities | Rs 3,136 Crore | Rs 2,999 Crore | Rs 2,834 Crore | Rs 2,607 Crore | Rs 1,936 Crore |
The following table presents key financial ratios for Fortis Healthcare:
| Ratio | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|
| Basic EPS (Rs.) | 10.26 | 7.93 | 7.80 | 7.35 | -1.45 |
| Diluted EPS (Rs.) | 10.26 | 7.93 | 7.80 | 7.35 | -1.45 |
| Book Value / Share (Rs.) | 118.11 | 113.33 | 107.30 | 92.83 | 88.98 |
| Dividend / Share (Rs.) | 1.00 | 1.00 | 1.00 | 0.00 | 0.00 |
| Face Value | 10 | 10 | 10 | 10 | 10 |
| Gross Profit Margin (%) | 21.26 | 18.94 | 18.46 | 19.17 | 11.19 |
| Operating Margin (%) | 16.30 | 13.97 | 13.45 | 13.91 | 3.98 |
| Net Profit Margin (%) | 10.25 | 9.22 | 9.70 | 13.39 | -2.57 |
| Return on Equity (%) | 8.68 | 7.81 | 8.12 | 8.98 | -1.79 |
| ROCE (%) | 10.50 | 9.52 | 7.69 | 7.49 | 1.61 |
| Return On Assets (%) | 5.65 | 4.50 | 4.73 | 4.67 | -0.98 |
| Current Ratio (X) | 0.92 | 0.45 | 0.99 | 0.89 | 0.84 |
| Quick Ratio (X) | 0.84 | 0.41 | 0.90 | 0.80 | 0.78 |
| Debt to Equity (x) | 0.25 | 0.11 | 0.10 | 0.16 | 0.19 |
| Interest Coverage Ratio (X) | 8.97 | 9.97 | 9.01 | 7.47 | 0.97 |
| Asset Turnover Ratio (%) | 0.58 | 0.54 | 0.09 | 0.08 | 36.12 |
| Inventory Turnover Ratio (X) | 69.89 | 0.00 | 0.00 | 0.00 | 52.50 |
| 3 Yr CAGR Sales (%) | 16.67 | 30.78 | 16.60 | 13.11 | -6.00 |
| 3 Yr CAGR Net Profit (%) | 2.07 | 147.56 | 177.58 | 14.11 | -67.59 |
| P/E (x) | 68.07 | 52.99 | 33.32 | 39.51 | -137.34 |
| P/B (x) | 5.91 | 4.14 | 2.71 | 3.55 | 2.45 |
| EV/EBITDA (x) | 33.04 | 25.16 | 17.90 | 21.26 | 36.26 |
| P/S (x) | 6.78 | 4.60 | 3.12 | 3.83 | 3.73 |
Fortis Healthcare Limited announced the closure of the trading window on September 26, 2025. The company also held analyst and investor meetings in September 2025.
The company announced a final dividend of Rs 1.00 per share (10%) on May 20, 2025, with an effective date of July 25, 2025.
Fortis Healthcare had rights issues in the past, with announcements on August 10, 2009, and December 24, 2008.
With the stock's last traded price at Rs 951.65, Fortis Healthcare has seen a gain of 2.03% from the previous close.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
